Appetite regulatory hormones in women with anorexia nervosa: Binge-eating/purging versus restricting type

Journal of Clinical Psychiatry

Volumn 76, Issue 1, 2015, Pages 19-24

  Eddy, Kamryn T ^a   Lawson, Elizabeth A ^a   Meade, Christina ^a   Meenaghan, Erinne ^a   Horton, Sarah E ^a   Misra, Madhusmita ^a   Klibanski, Anne ^a   Miller, Karen K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; LEPTIN; PEPTIDE YY;

ADULT; ANOREXIA NERVOSA; ARTICLE; BINGE EATING PURGING ANOREXIA NERVOSA; BODY WEIGHT; CONTROLLED STUDY; DSM-5; EATING DISORDER; FEEDING BEHAVIOR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; NEUROENDOCRINE DISEASE; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESTRICTING TYPE ANOREXIA NERVOSA; APPETITE; BINGE-EATING DISORDER; BLOOD; CLASSIFICATION; COMORBIDITY; COMPARATIVE STUDY; PHYSIOLOGY; YOUNG ADULT;

ADULT; ANOREXIA NERVOSA; APPETITE; BINGE-EATING DISORDER; BRAIN-DERIVED NEUROTROPHIC FACTOR; COMORBIDITY; FEMALE; HUMANS; LEPTIN; PEPTIDE YY; YOUNG ADULT;

EID: 84925352938     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.13m08753     Document Type: Article

References (35)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA: American Psychiatric Press; 2013.
2. Eddy KT, Keel PK, Dorer DJ, et al. Longitudinal comparison of anorexia nervosa subtypes. Int J Eat Disord. 2002;31(2):191-201.
3. Eddy KT, Dorer DJ, Franko DL, et al. Diagnostic crossover in anorexia nervosa and bulimia nervosa: implications for DSM-V. Am J Psychiatry. 2008;165(2):245-250.
4. Miller KK. Endocrine effects of anorexia nervosa. Endocrinol Metab Clin North Am. 2013;42(3):515-528.
5. Ingalls AM, Dickie MM, Snell GD. Obese, a new mutation in the house mouse. J Hered. 1950;41(12):317-318.
6. Batterham RL, Heffron H, Kapoor S, et al. Critical role for peptide YY in protein-mediated satiation and body-weight regulation. Cell Metab. 2006;4(3):223-233.
7. Unger TJ, Calderon GA, Bradley LC, et al. Selective deletion of Bdnf in the ventromedial and dorsomedial hypothalamus of adult mice results in hyperphagic behavior and obesity. J Neurosci. 2007;27(52):14265-14274.
8. Monteleone P, Maj M. Dysfunctions of leptin, ghrelin, BDNF and endocannabinoids in eating disorders: beyond homeostatic regulation of food intake. Psychoneuroendocrinology. 2013;38(3):312-330.
9. Lawson EA, Eddy KT, Donoho D, et al. Appetite-regulating hormones cortisol and peptide YY are associated with disordered eating psychopathology, independent of body mass index. Eur J Endocrinol. 2011;164(2):253-261.
10. Misra M, Miller KK, Tsai P, et al. Elevated peptide YY levels in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab. 2006;91(3):1027-1033.
11. Nakahara T, Kojima S, Tanaka M, et al. Incomplete restoration of the secretion of ghrelin and PYY compared to insulin after food ingestion following weight gain in anorexia nervosa. J Psychiatr Res. 2007;41(10):814-820.
12. Germain N, Galusca B, Grouselle D, et al. Ghrelin and obestatin circadian levels differentiate bingeing-purging from restrictive anorexia nervosa. J Clin Endocrinol Metab. 2010;95(6):3057-3062.
13. Kojima S, Nakahara T, Nagai N, et al. Altered ghrelin and peptide YY responses to meals in bulimia nervosa. Clin Endocrinol (Oxf). 2005;62(1):74-78.
14. Monteleone P, Martiadis V, Rigamonti AE, et al. Investigation of peptide YY and ghrelin responses to a test meal in bulimia nervosa. Biol Psychiatry. 2005;57(8):926-931.
15. Sedlackova D, Kopeckova J, Papezova H, et al. Comparison of a high-carbohydrate and high-protein breakfast effect on plasma ghrelin, obestatin, NPY and PYY levels in women with anorexia and bulimia nervosa. Nutr Metab (Lond). 2012;9(1):52.
16. Kernie SG, Liebl DJ, Parada LF. BDNF regulates eating behavior and locomotor activity in mice. EMBO J. 2000;19(6):1290-1300.
17. Rios M. BDNF and the central control of feeding: accidental bystander or essential player? Trends Neurosci. 2013;36(2):83-90.
18. Brandys MK, Kas MJ, van Elburg AA, et al. A meta-analysis of circulating BDNF concentrations in anorexia nervosa. World J Biol Psychiatry. 2011;12(6):444-454.
19. Ribasés M, Gratacòs M, Fernández-Aranda F, et al. Association of BDNF with restricting anorexia nervosa and minimum body mass index: a family-based association study of eight European populations. Eur J Hum Genet. 2005;13(4):428-434.
20. Saito S, Watanabe K, Hashimoto E, et al. Low serum BDNF and food intake regulation: a possible new explanation of the pathophysiology of eating disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(2):312-316.
21. Grinspoon S, Gulick T, Askari H, et al. Serum leptin levels in women with anorexia nervosa. J Clin Endocrinol Metab. 1996;81(11):3861-3863.
22. Ferron F, Considine RV, Peino R, et al. Serum leptin concentrations in patients with anorexia nervosa, bulimia nervosa and non-specific eating disorders correlate with the body mass index but are independent of the respective disease. Clin Endocrinol (Oxf). 1997;46(3):289-293.
23. Hebebrand J, Blum WF, Barth N, et al. Leptin levels in patients with anorexia nervosa are reduced in the acute stage and elevated upon short-term weight restoration. Mol Psychiatry. 1997;2(4):330-334.
24. Haas V, Onur S, Paul T, et al. Leptin and body weight regulation in patients with anorexia nervosa before and during weight recovery. Am J Clin Nutr. 2005;81(4):889-896.
25. Monteleone P, Martiadis V, Colurcio B, et al. Leptin secretion is related to chronicity and severity of the illness in bulimia nervosa. Psychosom Med. 2002;64(6):874-879.
26. Lawson EA, Donoho D, Miller KK, et al. Hypercortisolemia is associated with severity of bone loss and depression in hypothalamic amenorrhea and anorexia nervosa. J Clin Endocrinol Metab. 2009;94(12):4710-4716.
27. Lawson EA, Donoho DA, Blum JI, et al. Decreased nocturnal oxytocin levels in anorexia nervosa are associated with low bone mineral density and fat mass. J Clin Psychiatry. 2011;72(11):1546-1551.
28. Lawson EA, Miller KK, Blum JI, et al. Leptin levels are associated with decreased depressive symptoms in women across the weight spectrum, independent of body fat. Clin Endocrinol (Oxf). 2012;76(4):520-525.
29. Miller KK, Meenaghan E, Lawson EA, et al. Effects of risedronate and low-dose transdermal testosterone on bone mineral density in women with anorexia nervosa: a randomized, placebo-controlled study. J Clin Endocrinol Metab. 2011;96(7):2081-2088.
30. Fairburn CG, Beglin S. Appendix II Eating Disorder Examination Questionnaire. In: Fairburn, CG, ed. Cognitive Behavior Therapy and Eating Disorders. New York, NY: Guildford Press; 2008.
31. Berg KC, Peterson CB, Frazier P, et al. Psychometric evaluation of the eating disorder examination and eating disorder examination-questionnaire: a systematic review of the literature. Int J Eat Disord. 2012;45(3):428-438.
32. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50-55.
33. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56-62.
34. le Roux CW, Batterham RL, Aylwin SJ, et al. Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology. 2006;147(1):3-8.
35. Nakazato M, Tchanturia K, Schmidt U, et al. Brain-derived neurotrophic factor (BDNF) and set-shifting in currently ill and recovered anorexia nervosa (AN) patients. Psychol Med. 2009;39(6):1029-1035.